Activation of these cells produces pro-thrombotic and pro-tumorigenic TF and activates STAT3-mediated IL-6, PAI-1, and MMP-2 production (black upward arrows), and RAS/PI3K/SyK/Ki67/cyclin D1 signaling pathways, leading to tumor growth. The gene discussed is CCND1; the disease is neoplasm.